FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69432
News▼ Bearish
MNA Brigham and Women's Hospital Nurses and Mass General Brigham to Negotiate on October 8 Ahead of Potential October 14 Indefinite Strike
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 15:48 UTC
LAST UPDATE2026-10-07 15:48 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A potential indefinite nurses strike at Brigham and Women's threatens hospital capacity and labor costs.
Labor action risk for Mass General Brigham
CATALYST TO WATCH
October 8 negotiation outcome
MAIN RISK
Strike averted, impact fades
FULL DISPATCH
Brigham and Women's Hospital nurses have been bargaining for more than a year to ensure safe patient care and secure the respect they deserve BOSTON, Oct. 7, 2026 /PRNewswire/ -- The Brigham and Women's Hospital MNA Bargaining Committee – nurses elected by their 4,000 colleagues – will...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Primary Partners Alliance Demonstrates Nearly $70 Lower PMPM Healthcare Costs Using Lightbeam Health Solutions2026-10-07 16:02 UTC
Primary Partners Alliance Demonstrates Nearly $70 Lower PMPM Healthcare Costs Using Lightbeam Health Solutions2026-10-07 16:02 UTC
→CORRELATIONshares Healthcare
Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs2026-10-07 16:15 UTC
Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs2026-10-07 16:15 UTC
←CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
←CORRELATIONshares Healthcare
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.